Gunther Derigs, MD
Articles
UFT/Leucovorin Plus Weekly Paclitaxel in the Treatment of Solid Tumors
Carsten Bokemeyer, MD;Jörg Thomas Hartmann, MD;Frank Mayer, MD;Lothar Kanz, MD;Joachim Von Pawel, MD;Gunther Derigs, MD;Michael Schröder, MD
October 1st 2000The palliation of symptoms and improvement of quality of life are important aspects of therapy in patients with incurable metastatic cancer. This article describes the preliminary results of a phase I study of uracil and tegafur, an orally available fluorouracil (5-FU) derivative combined with oral leucovorin plus weekly intravenous paclitaxel.
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: August 26th 2011 | Updated: December 27th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: May 13th 2013 | Updated: December 27th 2024
A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
